Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trialShukui Qin, Yabing Guo, Jian Zhou et al.|The Lancet|2023Cited by 514
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestriesAbdul Rouf Banday, Marylyn D. Ritchie, Ludmila Prokunina‐Olsson et al.|Nature Genetics|2022Cited by 142
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasiaLaura E. Pascal, Zhou Wang, Khalid Z. Masoodi et al.|Journal of Endocrinology|2017Cited by 17